Charles J. Homcy - 29 Jun 2021 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Reporting relationship: Director
Issuer ticker: PLRX
Reported as of: 29 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Jun 2021, 20:37:03 UTC
Prior SEC filing: 22 Jun 2021
Next SEC filing: 06 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Mike Ouimette, attorney-in-fact

Key filing fact

Charles J. Homcy filed Form 4 for PLIANT THERAPEUTICS, INC. (PLRX) on 30 Jun 2021.

Key facts

This page summarizes Charles J. Homcy's Form 4 filing for PLIANT THERAPEUTICS, INC. (PLRX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 30 Jun 2021, 20:37.

Change

Previous filing in this sequence was filed on 22 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLRX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +13,286
Change %
Price: $0.000000
Shares after: 13,286
Date: 29 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,286
Exercise price: $28.20
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter following June 29, 2021 for three calendar quarters and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 29, 2021 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.

SEC remarks

Exhibit 24 - Power of Attorney